Tenon Medical, Inc. (TNON)
Tenon Medical, Inc. (TNON)
| Income Statement | 2026-03-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|
| Revenue | 1,379,000 | 1,173,000 | 564,000 | |
| Cost of revenue | 434,000 | 400,000 | 319,000 | |
| Gross profit | 945,000 | 773,000 | 245,000 | |
| Research and development | 662,000 | 428,000 | 503,000 | |
| Sales and marketing | 1,858,000 | 1,538,000 | 1,119,000 | |
| General and administrative | 1,705,000 | 2,199,000 | 1,480,000 | |
| Total operating expenses | 4,225,000 | 4,165,000 | 3,102,000 | |
| Loss from operations | -3,280,000 | -3,392,000 | -2,857,000 | |
| Gain on investments | 25,000 | 53,000 | 88,000 | |
| Interest expense | 176,000 | NaN | 0 | |
| Other expense | -45,000 | NaN | 0 | |
| Total other (expense) income, net | -196,000 | 53,000 | 88,000 | |
| Net loss | -3,476,000 | -3,339,000 | -2,769,000 | |
| Foreign currency translation adjustment | NaN | NaN | 0 | |
| Total comprehensive loss | NaN | -3,339,000 | -2,769,000 | |
| Basic EPS | -0.31 | -0.4 | -0.36 | |
| Diluted EPS | 0.31 | -0.4 | -0.36 | |
| Basic Average Shares | 11,268 | 8,250 | 7,591 | |
| Diluted Average Shares | 11,268 | 8,250 | 7,591 | |